Financials
Financial year 2026
Gross margin
€ -14,524
▼ 20% vs 2025
Profit
Growing€ 70,264
▲ 178% vs 2025
Jay Therapeutics from Gent, company number BE0771305101, closed financial year 2026 with a result of € 70,264 after tax. For that financial year Jay Therapeutics recorded a gross margin of € -14,524 and equity of € 10,237. Compared with financial year 2025, the result moved from € -89,854 to € 70,264. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 24, 2026.
What happened at Jay Therapeutics?
What happened at Jay Therapeutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 70,264. Source: NBB ↗
- New establishment in Gent. KBO
- V-Bio Fund 2 NV became a director. NBB
- Griet Vanpoucke became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.6 million loss in 2022 to € 70,264 profit in 2026.
Paid € 121,229 in corporate taxes since 2022.
Best year ever: 2026, with € 70,264 profit.
A new publication or filing at Jay Therapeutics? We notify you, reason included.
Follow Jay TherapeuticsNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Jay Therapeutics are V-Bio Fund 2 NV and Griet Vanpoucke. The same people are also behind ATB THERAPEUTICS.
Directors
According to the 2026 annual accounts
since 2021
Griet Vanpoucke
Director
since 2021
Establishments
Establishment units
Physical locations of this company
Pieter van Reysschootlaan 2 box 104
9051 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
CD-Vastgoed
€ 437,585 gross margin · 2025
V-BIO PARTNERS 1
€ -2,244 gross margin · 2025
V-BIO MANAGEMENT 1
€ 822,886 revenue · 2025
V-Bio Fund 1
€ -903,749 gross margin · 2025
V-Bio Co-Invest 1-1
€ -16,692 gross margin · 2025
+8 more
Details
- Company number
- 0771.305.101
- VAT number
- BE 0771.305.101
- Registered office
- Pieter van Reysschootlaan 2 bus 104, 9051 Gent
- Names & denominations
- Jay Therapeutics
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 July 2021
- Peppol
- Not registered
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied